Mr. David Kennedy joins Girindus as Director of Operations; Dr. Kathryn Ackley assumes leadership of Project Management

Mr. Kennedy received his B.S. Degree in Chemical Engineering at Clarkson University in Potsdam, NY. Previously, he worked for Pfizer in the areas of process engineering, bio-process development, commercial API production, and production of sterile injectables.

In a related move, Dr. Kathryn Ackley has assumed leadership of Girindus' Project Management group. In her new role, Dr. Ackley will manage the commercial aspects of manufacturing programs; she will be the main interface between clients and Girindus' operating and commercial groups. 'Kathy has the unique skills to successfully bridge the technical and commercial interface', said Dr. Laskovics. 'She has led both the Analytics and Operations groups, while playing a key role in supporting the Sales Function.'

Dr. Ackley earned a Bachelor's degree in Chemistry from the University of Kentucky and both a Master's and a Ph.D. degree in Analytical Chemistry from the University of Cincinnati. She joined Girindus in 2001 as an Analytical Chemist and has taken on positions of increasing responsibility. She became Section Head of the Analytics Group in 2003, Production Manager in 2006 and Director of Operations in 2008. Dr. Ackley was a 2006 recipient of the Solvay President's Award for Excellence.

About Girindus

Girindus (www.girindus.com), a member of Solvay Organics is a global provider of innovative drug actives and intermediates under cGMP through all clinical phases to commercialization. Girindus is a recognized leader in manufacturing Oligonucleotide therapeutics.

Sprache:       Deutsch

Unternehmen:   Girindus AG Buchenallee 20 51427 Bergisch Gladbach       DeutschlandInternet:      www.girindus.com

Girindus AG
Investor Relations
Markus Georgi
T: +49 2204 / 926 900
F: +49 2204 / 926 990
mgeorgi@girindus.com